Scientech Research LLC’s RxSight RXST Stock Holding History

Scientech Research LLC’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,345	Closed	-$108K	–	697
2025 Q4	$108K	Buy	+10,345	New	+$104K	0.07%	402

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Scientech Research LLC's RXST Position: Q1 2026 in Review

Scientech Research LLC sold out of RxSight (RXST) in Q1 2026, closing a stake of 10,345 shares — an estimated $108K sold.

Scientech Research LLC first reported a position in RXST in Q4 2025 and held it in 1 quarter. The position peaked at $108K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Scientech Research LLC reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
Scientech Research LLC sold 10,345 RxSight shares in Q1 2026, an estimated $108K.
Scientech Research LLC first reported a position in RxSight in Q4 2025 and held it in 1 quarter.
Scientech Research LLC's RxSight position peaked at $108K in Q4 2025.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.